On a snapshot day in 2012, almost 47,000 clients received pharmacotherapy treatment for their opioid dependence at 2,226 dosing points around Australia. As in previous years, methadone was the most common pharmacotherapy drug, with around two-thirds (68%) of clients treated with this drug. There were 1,768 prescribers of opioid pharmacotherapy drugs, an increase of 14% from 2011.
ISSN 1447-6746; ISBN 978-1-74249-432-6; Cat. no. HSE 136; 68pp.; $12
Publication table of contents
- Preliminary material
- Title and verso pages
- Body section
- 1 Introduction
- What are opioid drugs?
- What problems can opioid dependence cause?
- What treatment is available?
- How is opioid pharmacotherapy provided in Australia?
- What information is included in the NOPSAD collection?
- What is the NOPSAD collection used for?
- 2 Clients
- 2.1 How many people receive pharmacotherapy treatment?
- 2.2 What drugs do clients receive?
- 2.3 Who receives pharmacotherapy treatment?
- 3 Prescribers
- 3.1 How are prescribers authorised?
- 3.2 Where do prescribers work?
- 3.3 How many clients do prescribers treat?
- 3.4 Does drug treatment vary between sectors?
- 4 Dosing points
- 4.1 Where are pharmacotherapy drugs provided?
- 4.2 Where do clients receive their pharmacotherapy drugs?
- 5 The opioid pharmacotherapy system in Australia
- End matter
- Appendix A: Additional tables
- Appendix B: Data quality statement
- Appendix C: Data requests and related data collections
- List of tables
- List of figures
- List of boxes
AIHW 2013. National opioid pharmacotherapy statistics annual data collection 2012. Drug treatment series 20. Cat. no. HSE 136. Canberra: AIHW.